The luminal M2 subgroup demonstrated higher scores for the immune response and ER modules, while luminal M1 tumors displayed higher scores for the tumor invasion and metastasis, proliferation and HER2 modules, again indicating differences in tumor aggressiveness between the subgroups. Here, ERBB2 is linked to neoplasm.